Nexeon MedSystems Inc. (NXNN) Research

Nexeon MedSystems Inc. operates as a medical device enterprise, dedicated to the innovation, production, and market launch of neurostimulation solutions. These solutions leverage electrical impulses to modulate neural activity, offering therapeutic interventions for a spectrum of neurological conditions. Their robust neurostimulation platform is engineered to serve a wide array of neurostimulator applications, encompassing deep brain stimulation (DBS), peripheral electrical nerve stimulation, sacral nerve stimulation, spinal cord stimulation, and vagus nerve stimulation, among other related fields. Among its key developments is the Viant, a Deep Brain Stimulation (DBS) system. This system is being advanced for Parkinson's disease treatment within the United States, while its European applications extend to cover Parkinson's disease, Essential Tremor, and Dystonia. Founded in 2015, Nexeon MedSystems Inc. maintains its operational base in Dallas, Texas.

Open Nexeon MedSystems Inc. (NXNN) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.